Early hematologic dynamics and their association with patient-reported symptom burden in breast cancer pharmacotherapy: a prospective cohort study

Key Points

• To investigate how early hematologic and inflammatory changes relate to symptom burden in breast cancer patients undergoing pharmacotherapy.
• Conducted a prospective cohort study among breast cancer patients receiving pharmacotherapy.
• Monitored hematologic and inflammatory changes early in treatment.
• Collected patient-reported symptoms at various time points.
• Identified significant associations between hematologic dynamics and the severity of patient-reported symptoms.
• Inflammatory changes corresponded with increased symptom burden during treatment.